Journals By Industry - Gastrointestinal Agents

PRINCETON, N.J. & WILMINGTON, Del. -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the...

SAN FRANCISCO -- Napo Pharmaceuticals, Inc. ("Napo") announced a legal victory today in a dispute with Salix Pharmaceuticals, Inc. ("Salix"). Salix filed a voluntary motion requesting the dismissal of a lawsuit in which...

RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at The 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2012 at 4:30...

NEW YORK -- Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP, SGYPU, SGYPW),a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the successful outcome of the Oral Hearing held December 14, 2011...

- Clinical Data Expected in 2012 with Potential to Reveal Multiple Registration Paths in Underserved Patient Populations - - Infinity Maintains Strong Financial Foundation with Cash Into 2014 - CAMBRIDGE, Mass. -- Infinity...

CAMBRIDGE, Mass. -- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2012 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time...

Strengths Strong OTC product portfolio. One of the leading global pharmaceutical companies. Long-established local manufacturing presence. Production of the influenza drug Relenza (zanamivir) which is also used as a preventative measure against avian...

Brand X preaches with a choir This month's Brand X is under some serious pressure. The combo drug is scheduled to go off-patent later this year, though one of its components became available...

Strengths One of the leading foreign pharmaceutical companies in Serbia. Extensive range of prescription medicines, as well as OTCs and animal health products. Long history of involvement in the Serbian market. Weaknesses Strong...

Strengths The largest Latvian pharmaceutical manufacturer and focused on export trade to the CIS and elsewhere. Strong presence on the Estonian market in both prescription and OTC markets. Controls leading Estonian producer Tallinn...

Company Monitor Indigenous Company Profiles Strengths Largest Latvian pharmaceutical manufacturer. Strong export markets in the CIS, particularly Russia and Ukraine. Pending foray into the Chinese market. In control of leading Estonian producer of...

Strengths One of the leading pharmaceutical producers in Egypt. Contract manufacturing for foreign players. Access to foreign capital. Also has veterinary products in its portfolio. According to IMS Health, APC ranks first in...

Strengths Financial and commercial strength resulting from merger. Recent investment in new API manufacturing plant. Strong historical standing on the Japanese market. Weaknesses Exclusive focus on ethical pharmaceuticals. Poor performance of domestic market...

Strengths Leading position in Alzheimer's disease, in which has a significant unmet medical need. Healthy financial position amid stagnating local market. Weaknesses Has only just started to penetrate the high growth market of...

Strengths...

Company Profiles Domestic Manufacturer Profiles Strengths...

Strengths Mylan is the leading distributor of prescription drugs by volume. In-house R&D activities. Particular focus on branded generic drugs and OTCs. Exporting around half of total output. The company claims to control...

An Arizona woman has filed a product liability lawsuit alleging that she suffered bone fractures in her feet as a result of taking popular heartburn drugs made by AstraZeneca, Pfizer and other pharmaceutical...

Thought Leaders and Regulators Have Reservations About the Use of Antibiotics in Treating IBS, According to Findings from Decision Resources BURLINGTON, Mass. -- Second graph, first sentence of release dated December 21, 2011...